Vanguard Group
HIMS icon

Vanguard Group’s Hims & Hers Health HIMS Stock Holding History

Vanguard Group’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$679M Buy
20,925,666
+1,407,651
+7% +$60.3M 0.01% 872
2025
Q3 		$1.11B Buy
19,518,015
+844,991
+5% +$43.3M 0.02% 662
2025
Q2 		$931M Buy
18,673,024
+194,280
+1% +$8.78M 0.02% 713
2025
Q1 		$546M Sell
18,478,744
-1,778,372
-9% -$66.1M 0.01% 942
2024
Q4 		$490M Buy
20,257,116
+2,020,722
+11% +$50.1M 0.01% 1044
2024
Q3 		$336M Buy
18,236,394
+1,765,240
+11% +$31.6M 0.01% 1263
2024
Q2 		$333M Buy
16,471,154
+2,160,962
+15% +$36M 0.01% 1208
2024
Q1 		$221M Buy
14,310,192
+136,907
+1% +$1.54M ﹤0.01% 1455
2023
Q4 		$126M Buy
14,173,285
+46,541
+0.3% +$344K ﹤0.01% 1737
2023
Q3 		$88.9M Buy
14,126,744
+428,671
+3% +$3.19M ﹤0.01% 1871
2023
Q2 		$129M Buy
13,698,073
+1,969,446
+17% +$19.5M ﹤0.01% 1715
2023
Q1 		$116M Buy
11,728,627
+408,217
+4% +$3.58M ﹤0.01% 1753
2022
Q4 		$72.6M Buy
11,320,410
+205,218
+2% +$1.17M ﹤0.01% 1979
2022
Q3 		$62M Sell
11,115,192
-109,706
-1% -$661K ﹤0.01% 2078
2022
Q2 		$50.8M Buy
11,224,898
+2,140,803
+24% +$9.13M ﹤0.01% 2188
2022
Q1 		$48.4M Sell
9,084,095
-2,005,218
-18% -$9.92M ﹤0.01% 2322
2021
Q4 		$72.6M Buy
11,089,313
+417,871
+4% +$3.02M ﹤0.01% 2145
2021
Q3 		$80.5M Buy
10,671,442
+1,920,388
+22% +$16.3M ﹤0.01% 2104
2021
Q2 		$95.3M Buy
8,751,054
+2,086,232
+31% +$24.8M ﹤0.01% 2021
2021
Q1 		$88.2M Buy
+6,664,822
New +$112M ﹤0.01% 2013

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group's HIMS Position: Q4 2025 in Review

Vanguard Group increased its Hims & Hers Health (HIMS) stake by 7.2% in Q4 2025, buying an estimated $60.3M and bringing the position to 20,925,666 shares worth $679M. The position accounts for 0.01% of the portfolio, ranked #872.

Vanguard Group first reported a position in HIMS in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.11B in Q3 2025. 486 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

  • Vanguard Group held 20,925,666 shares of Hims & Hers Health worth $679M as of Q4 2025.
  • Vanguard Group bought 1,407,651 Hims & Hers Health shares in Q4 2025, an estimated $60.3M.
  • Hims & Hers Health made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #872 holding.
  • Vanguard Group first reported a position in Hims & Hers Health in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Hims & Hers Health position peaked at $1.11B in Q3 2025.
  • 486 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.